Role of α2-plasmin inhibitor in the appearance of fibrinolytic activity during urokinase administration, and an evaluation of the optimal urokinase dosage-Reference-Cited by-同舟云学术

Role of α2-plasmin inhibitor in the appearance of fibrinolytic activity during urokinase administration, and an evaluation of the optimal urokinase dosage

Published:1979-01 Issue:3-4 Volume:16 Page:393-400
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Hayashi Shigeru,Yamada Kaneo

Publisher

Elsevier BV

Subject

Hematology

Reference15 articles.

1. The maintenance of a sustained thrombolytic state in man. I. Induction and effects;Fletcher;J. Clin. Invest.,1959

2. The maintenace of a sustained thrombolytic state in man. II Clincal observations on patients with myocardial infarction and other thromboembolic disorders;Fletcher;J. Clin. Invest.,1959

3. Thrombosis and urokinase;Paoletti,1977

4. Effect of α2-plasmin inhibitor on fibrin clot lysis;Aoki,1979

5. The behavior of α2-plasmin inhibitor in fibrinolytic states;Aoki;J. Clin. Invest.,1977

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct evidence for systemic fibrinogenolysis in a patient with metastatic prostatic cancer;Thrombosis Research;1992-06

2. Release of alpha 2-plasmin inhibitor from plasma fibrin clots by activated coagulation factor XIII. Its effect on fibrinolysis.;Journal of Clinical Investigation;1986-03-01

3. The fibrinolytic system in man;Critical Reviews in Oncology/Hematology;1986-01

4. Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activator.;Circulation;1985-12

5. Coronary thrombolysis: Pharmacological considerations with emphasis on tissue-type plasminogen activator (t-PA);Biochemical Pharmacology;1984-06